Analogs of 17-hydroxywortmannin as PI3K inhibitors

Details for Australian Patent Application No. 2005295859 (hide)

Owner Wyeth

Inventors Gilbert, Adam Matthew; Yu, Ker; Gu, Jianxin; Kaplan, Josh; Bursavich, Matthew Gergory; Cai, Ping; Zask, Arie

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2005295859

PCT Pub. Number WO2006/044453

Priority 60/617,654 13.10.04 US

Filing date 13 October 2005

Wipo publication date 27 April 2006

International Classifications

C07J 73/00 (2006.01) Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of one or two carbon atoms by hetero atoms

A61K 31/352 (2006.01) - condensed with carbocyclic rings, e.g. cannabinols, methantheline

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

7 June 2007 PCT application entered the National Phase

  PCT publication WO2006/044453 Priority application(s): WO2006/044453

13 December 2007 Amendment Made

  The nature of the amendment is: Amend the co-inventors to read Yu, Ker; Gu, Jianxin; Kaplan, Josh; Cai, Ping; Zhu, Tianmen and Zask, Arie

22 October 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005295860-1-(hetero)aryl-3-amino-pyrollidine derivatives for use as mGluR3 receptor antagonists

2005295855-CGRP receptor antagonists